Accretion Pharmaceuticals Ltd vs Albert David Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 14, 2026

Key Highlights

The Latest Trading Price of Accretion Pharmaceuticals Ltd is ₹ 121.4 as of 14 May 15:30 . The P/E Ratio of Accretion Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Albert David Ltd changed from 9.7 on March 2021 to 26.9 on March 2025 . This represents a CAGR of 22.63% over 5 years The Market Cap of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Albert David Ltd changed from ₹ 215.12 crore on March 2021 to ₹ 463.25 crore on March 2025 . This represents a CAGR of 16.58% over 5 years The revenue of Accretion Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Albert David Ltd for the Mar '26 is ₹ 61.03 crore as compare to the Dec '25 revenue of ₹ 102.33 crore. This represent the decline of -40.36% The ebitda of Accretion Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Albert David Ltd for the Mar '26 is ₹ -22.08 crore as compare to the Dec '25 ebitda of ₹ 23.22 crore. This represent the decline of -195% The net profit of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Albert David Ltd changed from ₹ 18.84 crore to ₹ -21.43 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Accretion Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Albert David Ltd changed from 15.47 % on March 2021 to 16.6 % on March 2025 . This represents a CAGR of 1.42% over 5 years .

About Accretion Pharmaceuticals Ltd

Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in 2014.
Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

About Albert David Ltd

Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta.
The Company belongs to a renowned industrial house of Kolkata, the 'Kothari Group'.
The Company's principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs.
It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers. ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.'87.

FAQs for the comparison of Accretion Pharmaceuticals Ltd and Albert David Ltd

Which company has a larger market capitalization, Accretion Pharmaceuticals Ltd or Albert David Ltd?

Market cap of Accretion Pharmaceuticals Ltd is 134 Cr while Market cap of Albert David Ltd is 402 Cr

What are the key factors driving the stock performance of Accretion Pharmaceuticals Ltd and Albert David Ltd?

The stock performance of Accretion Pharmaceuticals Ltd and Albert David Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Pharmaceuticals Ltd and Albert David Ltd?

As of May 14, 2026, the Accretion Pharmaceuticals Ltd stock price is INR ₹121.4. On the other hand, Albert David Ltd stock price is INR ₹704.65.

How do dividend payouts of Accretion Pharmaceuticals Ltd and Albert David Ltd compare?

To compare the dividend payouts of Accretion Pharmaceuticals Ltd and Albert David Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.